Home » Topics » Briefs » Other news to note

Other news to note
RSS

Aptevo Therapeutics to sell hyperimmune commercial products to Saol Therapeutics

Sep. 5, 2017

Oncodesign acquires Bertin Pharma's pharmaceutical and biotech services business

Sep. 4, 2017

ImMAGE Biotherapeutics terminates operations

Sep. 1, 2017

Heptares begins leukotriene receptor modulator collaboration with Juntendo University

Sep. 1, 2017

Horizon Discovery completes acquisition of GE Healthcare Dharmacon

Sep. 1, 2017

Daiichi Sankyo terminates agreement with Charleston Laboratories

Sep. 1, 2017

CSL Behring to acquire Calimmune

Aug. 31, 2017

Thermo Fisher Scientific announces completion of its acquisition of Patheon

Aug. 30, 2017

Mazor Robotics and Medtronic enter next phase of strategic partnership

Aug. 30, 2017

Celgene exercises option to extend collaboration with Forma

Aug. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...